Streetbeat News

Stock Prices

CLGN

CollPlant Biotechnologies (NASDAQ:CLGN) reported Q3 earnings with an EPS of $-0.35, missing estimates by 169.23% compared to the expected $-0.13. Revenue decreased by $66 thousand from the same period last year. In the previous quarter, the company beat EPS estimates by $0.51, which led to a 5.23% share price increase the following day.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 12:10 pm

GLD

SPY

U.S. stock markets closed higher on Tuesday, with consumer discretionary shares leading gains and healthcare sector losses. The Conference Board's consumer confidence index rose, and home prices increased. Asia markets showed mixed performance, with Japan's Nikkei 225 and China's Shanghai Composite down, while Australia's S&P/ASX 200 gained. European markets were mostly up, with the STOXX 600, Germany's DAX, and France's CAC seeing gains, but the UK's FTSE 100 traded lower. Commodities saw crude oil prices rise and gold cross $2,000. U.S. futures were up in early trading, and the U.S. Dollar Index strengthened slightly.

Portfolio Pulse from Akanksha Bakshi

November 29, 2023 | 12:08 pm

PDCO

Patterson Companies has revised its FY24 adjusted EPS guidance to $2.35-$2.45, down from the previous forecast of $2.45-$2.55. This new guidance is below the consensus estimate of $2.50.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:05 pm

WOOF

Petco Health and Wellness (NASDAQ:WOOF) reported Q3 earnings with an EPS of $-0.05, significantly missing the estimated $0.02. Revenue also declined by $7 million compared to the same period last year. Despite a previous quarter's EPS miss resulting in a share price increase, the current substantial miss could negatively impact investor sentiment.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 12:05 pm

PDCO

Patterson Cos (NASDAQ:PDCO) reported Q2 earnings with an EPS of $0.5, missing estimates by 13.79% against the expected $0.58. Revenue increased by $26.77 million from the same period last year. In the previous quarter, a miss on EPS resulted in a 2.28% share price drop the following day. Historical earnings show variability in surpassing estimates.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 12:05 pm

GBTC

MSTR

Andrew Tate compared Michael Saylor's responsible business practices at MicroStrategy with Sam Bankman-Fried's fraudulent activities at FTX. Tate highlighted Saylor's net-benefit approach to business, contrasting it with Bankman-Fried's 0-benefit strategy, which led to his conviction on fraud charges. Tate also discussed the potential SEC approval of a Bitcoin ETF, mentioning several contenders for the ETF including Grayscale, Ark/21 Shares, Bitwise, BlackRock, VanEck, WisdomTree, Valkyrie, Invesco Galaxy, and Fidelity Wise Origin.

Portfolio Pulse from Mehab Qureshi

November 29, 2023 | 12:04 pm

CRWD

JP Morgan analyst Brian Essex has maintained an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $210 to $230.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:03 pm

TUYA

Morgan Stanley analyst Yang Liu has upgraded Tuya Inc. (NYSE:TUYA) from Equal-Weight to Overweight and set a price target of $2.7.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:03 pm

PDCO

Patterson Companies, Inc. (PDCO) reported Q2 adjusted EPS of $0.50, missing the consensus estimate of $0.58 by 13.79%, and a 20.63% decrease from $0.63 EPS last year. Sales were $1.65B, missing the $1.70B estimate by 2.84%, but marked a 1.65% increase from $1.63B in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 12:02 pm

ATRC

AtriCure (NASDAQ:ATRC) has received 5 analyst ratings in the last quarter, with 3 bullish and 2 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for AtriCure is $52.8, with a high of $60.00 and a low of $49.00, representing a 17.5% decrease from the previous target of $64.00. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 12:00 pm